3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
93
Leukemia
70
Lymphoma
52
Leukemia, Myeloid, Acute
41
Burkitt Lymphoma
36
Myelodysplastic Syndromes
32
Lymphoma, Non-Hodgkin
27
Hodgkin Disease
27
Lymphoma, Mantle-Cell
24
Leukemia, Lymphocytic, Chronic, B-Cell
23
Recurrence
21
Lymphoma, Large B-Cell, Diffuse
21
Graft vs Host Disease
21
Lymphoma, Follicular
19
Congenital Abnormalities
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Multiple Myeloma
17
Leukemia, Myeloid, Accelerated Phase
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Myeloproliferative Disorders
15
Leukemia, Myelomonocytic, Chronic
15
Blast Crisis
15
Lymphoma, B-Cell, Marginal Zone
14
Leukemia, Myeloid, Chronic-Phase
13
Lymphoma, Large-Cell, Immunoblastic
12
Hematologic Neoplasms
12
Primary Myelofibrosis
11
Lymphoma, Large-Cell, Anaplastic
11
Breast Neoplasms
11
Neoplasms, Plasma Cell
10
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
63
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
24
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
durvalumab
11
Nivolumab
11
rucaparib
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
Methotrexate
×
Clear all
NCT01432145
2019-07-09
6MP
University of Oxford
Phase 2
Completed
74 enrolled
13 charts